Fluarix Tetra

Fluarix Tetra

vaccine, influenza

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig
Concise Prescribing Info
Contents
Quadrivalent flu vaccine (split virion, inactivated) 2020 Southern Hemisphere strains
Indications/Uses
Prevention of flu disease caused by flu virus types A & B contained in the vaccine in adult & childn >6 mth.
Dosage/Direction for Use
IM 0.5 mL single inj in deltoid or anterolateral thigh. Childn 6 mth to <9 yr who have not been previously vaccinated Administer 2nd dose of 0.5 mL after at least a 4 wk interval.
Special Precautions
Postpone vaccination in patients w/ acute severe febrile illness. Adequate immune response may not be elicited in patients w/ immunodeficiency. Do not administer intravascularly. Patients w/ thrombocytopenia or any coagulation disorder. Syncope. Pregnancy & lactation.
Adverse Reactions
Myalgia; inj site pain, fatigue. Headache; GI symptoms (including nausea, vomiting, diarrhea &/or abdominal pain); sweating; arthralgia; inj site redness, swelling, shivering, fever & inj site induration.
Drug Interactions
False +ve ELISA serologic tests for HIV-1, hepatitis C & HTLV-1 may occur.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07BB - Influenza vaccines ; Used for active immunizations.
Presentation/Packing
Form
Fluarix Tetra vaccine inj 15 mcg/0.5 mL
Packing/Price
0.5 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in